始于1953年,專注于化學制藥/維生素及營養保健品/現代中藥/生物農獸藥等領域,集研發/生產/服務于一體的現代化醫藥健康產業集團
華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)集團(tuan)(tuan)有(you)(you)限責任公司(si)(簡稱:華(hua)(hua)藥(yao)(yao)(yao)(yao)集團(tuan)(tuan))位于河(he)北(bei)(bei)省省會石家莊(zhuang)市(shi)(shi)。前(qian)身華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)廠(chang)是(shi)中(zhong)國(guo)(guo)(guo)“一(yi)五”計(ji)劃期間(jian)的重(zhong)(zhong)點建(jian)設(she)項目,1953年(nian)6月(yue)開始籌建(jian),1958年(nian)6月(yue)建(jian)成投產(chan),開創(chuang)了我(wo)國(guo)(guo)(guo)大規模生(sheng)產(chan)抗生(sheng)素的歷史,為人類(lei)健康事業(ye)(ye)、民族制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)工業(ye)(ye)發展和改變我(wo)國(guo)(guo)(guo)缺醫少(shao)藥(yao)(yao)(yao)(yao)局(ju)面做出了重(zhong)(zhong)要貢獻。1992年(nian)重(zhong)(zhong)組(zu)設(she)立華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)股份有(you)(you)限公司(si),1994年(nian)在(zai)上交所(suo)掛牌上市(shi)(shi)(股票名稱:華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)600812)。1996年(nian)1月(yue),華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)廠(chang)正(zheng)式改制(zhi)(zhi)(zhi)(zhi)為國(guo)(guo)(guo)有(you)(you)獨資公司(si)——華(hua)(hua)北(bei)(bei)制(zhi)(zhi)(zhi)(zhi)藥(yao)(yao)(yao)(yao)集團(tuan)(tuan)有(you)(you)限責任公司(si)。2009年(nian)6月(yue),經河(he)北(bei)(bei)省政府(fu)批準,冀中(zhong)能源集團(tuan)(tuan)對華(hua)(hua)藥(yao)(yao)(yao)(yao)集團(tuan)(tuan)實(shi)施了重(zhong)(zhong)組(zu)。
多年來,華藥(yao)集(ji)(ji)團秉承“人(ren)類(lei)健康(kang)至(zhi)上,質(zhi)量(liang)永遠(yuan)第一”的(de)企業(ye)宗(zong)旨,持續(xu)創新,穩健經營(ying),逐步(bu)壯大,經營(ying)范圍(wei)不(bu)斷拓展(zhan)(zhan),發(fa)展(zhan)(zhan)業(ye)績保(bao)持優良(liang),主(zhu)要經濟技術(shu)指標始終處于國(guo)內同行業(ye)前列。截至(zhi)2018年底,華藥(yao)集(ji)(ji)團資產(chan)(chan)總額(e)206億元,職工(gong)近1.5萬人(ren),擁有四(si)十多家子(zi)(分)公(gong)司,擁有微生(sheng)(sheng)物(wu)(wu)(wu)(wu)(wu)藥(yao)物(wu)(wu)(wu)(wu)(wu)國(guo)家工(gong)程研究中(zhong)心、抗體(ti)藥(yao)物(wu)(wu)(wu)(wu)(wu)研制國(guo)家重點實(shi)驗室(shi)、抗生(sheng)(sheng)素酶催化與(yu)結(jie)晶技術(shu)國(guo)家地方(fang)聯合工(gong)程實(shi)驗室(shi)三個創新平臺,主(zhu)要產(chan)(chan)品涉(she)及(ji)化學制藥(yao)、現(xian)代生(sheng)(sheng)物(wu)(wu)(wu)(wu)(wu)技術(shu)藥(yao)物(wu)(wu)(wu)(wu)(wu)、維生(sheng)(sheng)素及(ji)營(ying)養保(bao)健品、現(xian)代中(zhong)藥(yao)、生(sheng)(sheng)物(wu)(wu)(wu)(wu)(wu)農獸藥(yao)等領域近千(qian)個品規,治療(liao)領域涵蓋抗感染類(lei)、心腦血管類(lei)、腎病、抗腫瘤及(ji)免疫調節類(lei)等,主(zhu)要生(sheng)(sheng)產(chan)(chan)單(dan)元的(de)工(gong)藝路線(xian)、生(sheng)(sheng)產(chan)(chan)布局全部(bu)按照歐美現(xian)行版(ban)、中(zhong)國(guo)新版(ban)GMP標準設計實(shi)施(shi),擁有具(ju)備(bei)國(guo)際領先水準的(de)現(xian)代化制藥(yao)生(sheng)(sheng)產(chan)(chan)平臺。